Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity
Status:
Not yet recruiting
Trial end date:
2024-12-26
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to test the safety and effectiveness of an injection study
drug in decreasing bilateral flank adiposity.
The main question it aims to answer is:
•How safe and effective is the injection study drug in removing bilateral flank adiposity
compared to a placebo?
Participants will be:
- Be given injections every month for 5 months over the right and left flanks.
- Be asked to be seen in the clinic for 13 visits and 3 phone call visits during a
duration of 1 year.